Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 5791510, 10 pages
http://dx.doi.org/10.1155/2016/5791510
Research Article

Activin A Stimulates Aromatase via the ALK4-Smad Pathway in Endometriosis

1State Key Laboratory of Reproductive Medicine, Center of Clinical Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
2Center of Reproductive Medicine, 174th Hospital of PLA, Xiamen 361000, China

Received 21 May 2016; Accepted 17 August 2016

Academic Editor: Limei Qiu

Copyright © 2016 Juan Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. C. Giudice and L. C. Kao, “Endometriosis,” The Lancet, vol. 364, no. 9447, pp. 1789–1799, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. S. E. Bulun, S. Yang, Z. Fang, B. Gurates, M. Tamura, and S. Sebastian, “Estrogen production and metabolism in endometriosis,” Annals of the New York Academy of Sciences, vol. 955, no. 1, pp. 75–85, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. T. L. Rižner, “Estrogen metabolism and action in endometriosis,” Molecular and Cellular Endocrinology, vol. 307, no. 1-2, pp. 8–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Huhtinen, M. Ståhle, A. Perheentupa, and M. Poutanen, “Estrogen biosynthesis and signaling in endometriosis,” Molecular and Cellular Endocrinology, vol. 358, no. 2, pp. 146–154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. W. Xiong, L. Zhang, L. Yu et al., “Estradiol promotes cells invasion by activating β-catenin signaling pathway in endometriosis,” Reproduction, vol. 150, no. 6, pp. 507–516, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. S. E. Bulun, Y.-H. Cheng, P. Yin et al., “Progesterone resistance in endometriosis: link to failure to metabolize estradiol,” Molecular and Cellular Endocrinology, vol. 248, no. 1-2, pp. 94–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Tremblay, G. E. Ringler, Y. Morel et al., “Regulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17cen→q25,” Journal of Biological Chemistry, vol. 264, no. 34, pp. 20458–20462, 1989. View at Google Scholar · View at Scopus
  8. S. E. Bulun, “Endometriosis,” The New England Journal of Medicine, vol. 360, no. 3, pp. 268–279, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Gori, C. Pellegrini, D. Staedler, R. Russell, C. Jan, and G. O. Canny, “Tumor necrosis factor-α activates estrogen signaling pathways in endometrial epithelial cells via estrogen receptor α,” Molecular and Cellular Endocrinology, vol. 345, no. 1-2, pp. 27–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Zhang, W. Xiong, Y. Xiong, H. Liu, and Y. Liu, “17 β-Estradiol promotes vascular endothelial growth factor expression via the Wnt/β-catenin pathway during the pathogenesis of endometriosis,” Molecular Human Reproduction, vol. 22, no. 7, pp. 526–535, 2016. View at Publisher · View at Google Scholar
  11. Z. Hou, L. Sun, L. Gao, L. Liao, Y. Mao, and J. Liu, “Cytokine array analysis of peritoneal fluid between women with endometriosis of different stages and those without endometriosis,” Biomarkers, vol. 14, no. 8, pp. 604–618, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Massagué, “TGF-β signal transduction,” Annual Review of Biochemistry, vol. 67, no. 1, pp. 753–791, 1998. View at Publisher · View at Google Scholar
  13. H. Hayashi, S. Abdollah, Y. Qiu et al., “The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling,” Cell, vol. 89, no. 7, pp. 1165–1173, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Imamura, M. Takase, A. Nishihara et al., “Smad6 inhibits signalling by the TGF-β superfamily,” Nature, vol. 389, no. 6651, pp. 622–626, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Nakao, M. Afrakhte, A. Morén et al., “Identification of Smad7, a TGFβ-inducible antagonist of TGF-β-signalling,” Nature, vol. 389, no. 6651, pp. 631–635, 1997. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Song, J. Keelan, and J. T. France, “Activin-A stimulates, while transforming growth factor β1, inhibits, chorionic gonadotrophin production and aromatase activity in cultured human placental trophoblasts,” Placenta, vol. 17, no. 8, pp. 603–610, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Mukasa, M. Nomura, T. Tanaka et al., “Activin signaling through type IB activin receptor stimulates aromatase activity in the ovarian granulosa cell-like human granulosa (KGN) cells,” Endocrinology, vol. 144, no. 4, pp. 1603–1611, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Nomura, R. Sakamoto, H. Morinaga, L. Wang, C. Mukasa, and R. Takayanagi, “Activin stimulates CYP19A gene expression in human ovarian granulosa cell-like KGN cells via the Smad2 signaling pathway,” Biochemical and Biophysical Research Communications, vol. 436, no. 3, pp. 443–448, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. R. W. Noyes, A. T. Hertig, and J. Rock, “Dating the endometrial biopsy,” American Journal of Obstetrics and Gynecology, vol. 122, no. 2, pp. 262–263, 1975. View at Google Scholar · View at Scopus
  20. M. Canis, J. G. Donnez, D. S. Guzick et al., “Revised American Society for Reproductive Medicine classification of endometriosis: 1996,” Fertility and Sterility, vol. 67, no. 5, pp. 817–821, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Hou, J. Zhou, X. Ma, L. Fan, L. Liao, and J. Liu, “Role of interleukin-1 receptor type II in the pathogenesis of endometriosis,” Fertility and Sterility, vol. 89, no. 1, pp. 42–51, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Luo, J. Xu, and N. Chegini, “The expression of smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-β,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 10, pp. 4967–4976, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Attar and S. E. Bulun, “Aromatase and other steroidogenic genes in endometriosis: translational aspects,” Human Reproduction Update, vol. 12, no. 1, pp. 49–56, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Chegini, Y. Zhao, R. S. Williams, and K. C. Flanders, “Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-β1 (TGFβ1), TGFβ2, TGFβ3, and TGFβ Type II receptor messenger ribonucleic acid and protein and contains [125I]TGFβ1-binding sites,” Endocrinology, vol. 135, no. 1, pp. 439–449, 1994. View at Google Scholar · View at Scopus
  26. T. Sandberg, B. Casslén, B. Gustavsson, and T. J. Benraad, “Human endothelial cell migration is stimulated by urokinase plasminogen activator: plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor β1; possible mechanism for paracrine stimulation of endometrial angiogenesis,” Biology of Reproduction, vol. 59, no. 4, pp. 759–767, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. S. M. Margarit, H. Sondermann, B. E. Hall et al., “Structural evidence for feedback activation by RasGTP of the Ras-specific nucleotide exchange factor SOS,” Cell, vol. 112, no. 5, pp. 685–695, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. N. J. Laping, E. Grygielko, A. Mathur et al., “Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity: SB-431542,” Molecular Pharmacology, vol. 62, no. 1, pp. 58–64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Kitawaki, T. Noguchi, T. Amatsu et al., “Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium,” Biology of Reproduction, vol. 57, no. 3, pp. 514–519, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Bukulmez, D. B. Hardy, B. R. Carr, R. A. Word, and C. R. Mendelson, “Inflammatory status influences aromatase and steroid receptor expression in endometriosis,” Endocrinology, vol. 149, no. 3, pp. 1190–1204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Dassen, C. Punyadeera, R. Kamps et al., “Estrogen metabolizing enzymes in endometrium and endometriosis,” Human Reproduction, vol. 22, no. 12, pp. 3148–3158, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. J.-F. Heilier, J. Donnez, S. Defrere, V. Van Kerckhove, O. Donnez, and D. Lison, “Serum dioxin-like compounds and aromatase (CYP19) expression in endometriotic tissues,” Toxicology Letters, vol. 167, no. 3, pp. 238–244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Hudelist, K. Czerwenka, J. Keckstein et al., “Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis,” Reproductive Sciences, vol. 14, no. 8, pp. 798–805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Ishihara, J. Kitawaki, N. Kado, H. Koshiba, S. Fushiki, and H. Honjo, “Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas,” Fertility and Sterility, vol. 79, no. 3, pp. 735–742, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Murakami, K. Nomura, K. Shinohara, T. Kasai, M. Shozu, and M. Inoue, “Danazol inhibits aromatase activity of endometriosis-derived stromal cells by a competitive mechanism,” Fertility and Sterility, vol. 86, no. 2, pp. 291–297, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Purohit, L. Fusi, J. Brosens, L. W. L. Woo, B. V. L. Potter, and M. J. Reed, “Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy,” Human Reproduction, vol. 23, no. 2, pp. 290–297, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. C. A. Piccinato, R. M. Neme, N. Torres et al., “Increased expression of CYP1A1 and CYP1B1 in ovarian/peritoneal endometriotic lesions,” Reproduction, vol. 151, no. 6, pp. 683–692, 2016. View at Publisher · View at Google Scholar
  38. B. Delvoux, P. Groothuis, T. D'Hooghe, C. Kyama, G. Dunselman, and A. Romano, “Increased production of 17β-estradiol in endometriosis lesions is the result of impaired metabolism,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 3, pp. 876–883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Colette, J. C. Lousse, S. Defrère et al., “Absence of aromatase protein and mRNA expression in endometriosis,” Human Reproduction, vol. 24, no. 9, pp. 2133–2141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. S. E. Bulun, Z. Lin, G. Imir et al., “Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment,” Pharmacological Reviews, vol. 57, no. 3, pp. 359–383, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Iempridee, S. Das, I. Xu, and J. E. Mertz, “Transforming growth factor β-induced reactivation of epstein-barr virus involves multiple smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene,” Journal of Virology, vol. 85, no. 15, pp. 7836–7848, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. O. Yoshino, G. Izumi, J. Shi et al., “Activin-A is induced by interleukin-1β and tumor necrosis factor-α and enhances the mRNA expression of interleukin-6 and protease-activated receptor-2 and proliferation of stromal cells from endometrioma,” Fertility and Sterility, vol. 96, no. 1, pp. 118–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M. C. Ferreira, C. A. Witz, L. S. Hammes et al., “Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum,” Molecular Human Reproduction, vol. 14, no. 5, pp. 301–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. D. M. de Kretser, R. E. O'Hehir, C. L. Hardy, and M. P. Hedger, “The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair,” Molecular and Cellular Endocrinology, vol. 359, no. 1-2, pp. 101–106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. F. M. Reis, S. Luisi, M. S. Abro et al., “Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis,” Human Reproduction, vol. 27, no. 5, pp. 1445–1450, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. M. P. Hedger, W. R. Winnall, D. J. Phillips, and D. M. de Kretser, “The regulation and functions of activin and follistatin in inflammation and immunity,” Vitamins and Hormones, vol. 85, pp. 255–297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. K. Yoshinaga, K. Mimori, H. Inoue et al., “Activin A enhances MMP-7 activity via the transcription factor AP-1 in an esophageal squamous cell carcinoma cell line,” International Journal of Oncology, vol. 33, no. 3, pp. 453–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. R. L. Jones, J. K. Findlay, P. G. Farnworth, D. M. Robertson, E. Wallace, and L. A. Salamonsen, “Activin A and inhibin a differentially regulate human uterine matrix metalloproteinases: potential interactions during decidualization and trophoblast invasion,” Endocrinology, vol. 147, no. 2, pp. 724–732, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. A. L. L. Rocha, P. Carrarelli, R. Novembri et al., “Activin A stimulates interleukin 8 and vascular endothelial growth factor release from cultured human endometrial stromal cells: possible implications for the pathogenesis of endometriosis,” Reproductive Sciences, vol. 19, no. 8, pp. 832–838, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Yu, Y. Wang, W.-H. Zhou, L. Wang, Y.-Y. He, and D.-J. Li, “Combination of estrogen and dioxin is involved in the pathogenesis of endometriosis by promoting chemokine secretion and invasion of endometrial stromal cells,” Human Reproduction, vol. 23, no. 7, pp. 1614–1626, 2008. View at Publisher · View at Google Scholar · View at Scopus